Asia Pacific | Singapore
8 May 2023
9:00am to 1:00pm
20 Science Park Rd Singapore Science Park 2, 117674 | Teletech Park Conference Room (Level 1, behind the Customer Service Counter)
Join us on 8 May 2023 as the PacBio HiFi Sequencing Experience Tour Roadshow Event is back in Singapore for its second consecutive year. Discover how HiFi sequencing is helping scientists find accurate and actionable genome-wide insights for the most important scientific discoveries.
There will be presentations by industry-leading scientists and the opportunity for peer-to-peer discussions and networking during this event. Whether you have a single sample or a multi-genome project, complete and accurate long-read sequencing is designed to support your desire to make an impact.
We look forward to meeting you in person.
Transportation Access:
1. Driving: There are ample parking lots available within Teletech Park.
2. Public Transport:
3. Private Hire: You may consider private hire options such as ComfortDelGro, Grab, Gojek, TADA, Ryde, etc.
4. Chartered Bus:
We also offer chartered bus services with the following schedule:
Highlights include:
Singapore | HiFi Sequencing Experience Tour Event | 8 May 2023 | 9:00am-1:00pm
TIME | TOPIC | SPEAKERS |
8:30am | Registrations | All |
9:00am | Welcome & Introduction | Lyndsey Lam |
9:05am | PacBio: Changing the Sequencing Game | Jennifer Hsu |
9:15am | Human Genomics | Edd Lee |
9:35am | A new age in cancer genomics research: from single-cell transcriptomics to liquid biopsy | Alex Sockell (virtual) |
9:50am | Deciphering the glial function of TDP-43 | Shuo-Chien Ling |
10:20am | Coffee break | |
10:30am | Microbial Metagenome Updates | Khi Pin Chua |
10:45am | Not all telomeres are equal: allele-specific telomere length measurement in aging-associated diseases | Dr. Shang Li |
11:15am | Increased Diagnostic Yield With Long Read Sequencing In Patients With Undiagnosed Neurodevelopmental Disorder | Dr. Saumya Shekhar Jamuar |
11:45am | Long-read Capture with Twist Target Enrichment System | Nicole Lee (Twist) |
11:55am | HiFi approach to targeted sequencing | Zuwei Qian |
12:10am | Customer Speaker 4 | |
12:15pm | Lunch / Revio Demonstration at SG Apps Lab | All / Service & Support Team |
REGISTER NOW
Director, Human Genomics Segment Marketing
PacBio
Marketing Manager, Oncology and Cancer Research
PacBio
Director of Marketing, Asia Pacific
PacBio
Senior Consultant, Genetics service, Dept of Paediatrics; Deputy Director (Clinical)
KK Women's and Children's Hospital; SingHealth Duke-NUS Institute of Precision Medicine
Associate Professor, Cancer and Stem Cell Biology; Director of NCRIS CRISPR core facility
Duke-NUS medical School
Associate Professor, Department of Physiology
NUS, Yong Loo Lin School of Medicine, Laboratory for Molecular Neurodegeneration
Shuo-Chien Ling, Ph.D.
Associate Professor, Department of Physiology
NUS, Yong Loo Lin School of Medicine, Laboratory for Molecular Neurodegeneration
My research investigates both fundamental and translational aspects of neuroscience combining multiple techniques and disciplines focusing on two major areas: mechanisms underlying molecular basis for synaptic plasticity and adult-onset neurodegenerative diseases. In particular, we elucidate gene-function relationships using disease-causing genes, including fragile X mental retardation protein (FMRP), TDP-43 (TAR-DNA binding protein-43 KDa), FUS/TLS (fused in sarcoma/translocated in liposarcoma), and C9ORF72 (chromosome 9 open reading frame 72).
During my undergraduate study in Chemical Engineering, I became fascinated in biology, particularly, neuroscience. After obtaining BSc and MSc at the National Tsing-Hua University (NTHU), Taiwan, I went on to complete my Ph.D. (2005) at the Neuroscience program at the University of Illinois at Urbana-Champaign, USA under Professors William Greenough and Vladimir Gelfand. After a short postdoc at Northwestern University, I moved to University of California, San Diego (UCSD) with Professor Don W. Cleveland. At October 2013, I started my group at the National University of Singapore (NUS), and promoted to Associate Professor at 2022.
Dr. Saumya Shekhar Jamuar, MBBS, MRCPCH (UK), FAMS, FACMG
Senior Consultant, Genetics service, Dept of Paediatrics; Deputy Director (Clinical)
KK Women's and Children's Hospital; SingHealth Duke-NUS Institute of Precision Medicine
Dr Saumya Jamuar is a Clinical Geneticist at KKH, serves as the Lead PI of the Singapore Childhood Undiagnosed Disease/ BRIDGES Programme and is the Clinical Director of the SingHealth Duke-NUS Institute of Precision Medicine. He was the Inaugural head of the SingHealth Duke-NUS Genomic Medicine Centre. He is the co-founder of Global Gene Corporation Pte Ltd.
He completed his Genetics Fellowship at Harvard Medical School. He is actively involved in research, has presented at both local and international meetings and has published in top tier journals including The New England Journal of Medicine and Nature Genetics. His research areas include rare genetic disorders, dysmorphology, skeletal dysplasia, and neurodevelopmental genetics. He was awarded the Young Investigator Award at the 2013 American Epilepsy Society meeting and is the recipient of the 2015 Singhealth Outstanding Young Researcher Award, Singhealth Outstanding Publish Award, and 2021 National Medical Research Council Clinician Scientist Award.
SPEAKER SPOTLIGHT
Dr. Shang Li, MBBS, PhD
Associate Professor, Cancer and Stem Cell Biology; Director of NCRIS CRISPR core facility
Duke-NUS Medical School
Dr. Shang Li is currently an Associate Professor in the Cancer and Stem Cell Biology program at Duke-NUS medical School. He obtained his MBBS degree from Beijing Medical University (Peking University, School of Medicine). He obtained his Ph.D. degree in Molecular Medicine from UTHSCSA under the supervision of Dr. WenHwa Lee (Member, Sinica Academia, ROC). For his postdoctoral training, he joined Dr. Elizabeth Blackburn’s laboratory at University of California San Francisco (UCSF). Dr. Blackburn was awarded the Nobel Prize in Physiology or Medicine in 2009 for her discovery of “how chromosomes are protected by telomeres and the enzyme telomerase”. He joined Duke-NUS Medical School since 2010. His lab focuses on the regulation of telomerase in human cancer cells and normal stem cells to develop therapeutic interventions for human cancer and aging. Dr. Li is also the director of NCRIS CRISPR core facility that provides service to research communities at Duke-NUS Medical School and NCCs. He has published over 50 papers and book chapters including: Nature, Science, Cell, Molecular Cell, Nature Cell Biology, Cancer Discovery, Nature Comm. etc. (h-index=28, i10-index=38).